These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 31185182)
1. What "The Cancer Genome Atlas" database tells us about the role of ATP-binding cassette (ABC) proteins in chemoresistance to anticancer drugs. Briz O; Perez-Silva L; Al-Abdulla R; Abete L; Reviejo M; Romero MR; Marin JJG Expert Opin Drug Metab Toxicol; 2019 Jul; 15(7):577-593. PubMed ID: 31185182 [No Abstract] [Full Text] [Related]
2. The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer. Wang Y; Wang Y; Qin Z; Cai S; Yu L; Hu H; Zeng S Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):291-306. PubMed ID: 33544643 [TBL] [Abstract][Full Text] [Related]
3. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo. Hu J; Zhang X; Wang F; Wang X; Yang K; Xu M; To KK; Li Q; Fu L Oncotarget; 2015 Dec; 6(42):44643-59. PubMed ID: 26556876 [TBL] [Abstract][Full Text] [Related]
4. Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance. Li S; Zhang W; Yin X; Xing S; Xie HQ; Cao Z; Zhao B Anticancer Agents Med Chem; 2015; 15(4):423-32. PubMed ID: 25929575 [TBL] [Abstract][Full Text] [Related]
5. ATP-binding cassette transmembrane transporters and their epigenetic control in cancer: an overview. Arrigoni E; Galimberti S; Petrini M; Danesi R; Di Paolo A Expert Opin Drug Metab Toxicol; 2016 Dec; 12(12):1419-1432. PubMed ID: 27459275 [TBL] [Abstract][Full Text] [Related]
6. Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit? Yu M; Ocana A; Tannock IF Cancer Metastasis Rev; 2013 Jun; 32(1-2):211-27. PubMed ID: 23093326 [TBL] [Abstract][Full Text] [Related]
7. Chemosensitization of hepatocellular carcinoma cells to sorafenib by β-caryophyllene oxide-induced inhibition of ABC export pumps. Di Giacomo S; Briz O; Monte MJ; Sanchez-Vicente L; Abete L; Lozano E; Mazzanti G; Di Sotto A; Marin JJG Arch Toxicol; 2019 Mar; 93(3):623-634. PubMed ID: 30659321 [TBL] [Abstract][Full Text] [Related]
8. ABC Transporters in the Development of Multidrug Resistance in Cancer Therapy. Dlugosz A; Janecka A Curr Pharm Des; 2016; 22(30):4705-4716. PubMed ID: 26932159 [TBL] [Abstract][Full Text] [Related]
9. Role of transportome in the pharmacogenomics of hepatocellular carcinoma and hepatobiliary cancer. Alonso-Peña M; Espinosa-Escudero RA; Soto-Muñiz M; Sanchon-Sanchez P; Sanchez-Martin A; Marin JJ Pharmacogenomics; 2019 Aug; 20(13):957-970. PubMed ID: 31486734 [TBL] [Abstract][Full Text] [Related]
10. The therapeutic potential of targeting ABC transporters to combat multi-drug resistance. Bugde P; Biswas R; Merien F; Lu J; Liu DX; Chen M; Zhou S; Li Y Expert Opin Ther Targets; 2017 May; 21(5):511-530. PubMed ID: 28335655 [TBL] [Abstract][Full Text] [Related]
12. ABC transporter superfamily. An updated overview, relevance in cancer multidrug resistance and perspectives with personalized medicine. Juan-Carlos PM; Perla-Lidia PP; Stephanie-Talia MM; Mónica-Griselda AM; Luz-María TE Mol Biol Rep; 2021 Feb; 48(2):1883-1901. PubMed ID: 33616835 [TBL] [Abstract][Full Text] [Related]
13. Cisplatin-induced chemoresistance in colon cancer cells involves FXR-dependent and FXR-independent up-regulation of ABC proteins. Herraez E; Gonzalez-Sanchez E; Vaquero J; Romero MR; Serrano MA; Marin JJ; Briz O Mol Pharm; 2012 Sep; 9(9):2565-76. PubMed ID: 22800197 [TBL] [Abstract][Full Text] [Related]
14. Expression of ABC-transport proteins in canine mammary cancer: consequences for chemotherapy. Honscha KU; Schirmer A; Reischauer A; Schoon HA; Einspanier A; Gäbel G Reprod Domest Anim; 2009 Jul; 44 Suppl 2():218-23. PubMed ID: 19754573 [TBL] [Abstract][Full Text] [Related]
15. ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward? Adamska A; Falasca M World J Gastroenterol; 2018 Aug; 24(29):3222-3238. PubMed ID: 30090003 [TBL] [Abstract][Full Text] [Related]
17. Relevance of multidrug resistance in the age of targeted therapy. Türk D; Szakács G Curr Opin Drug Discov Devel; 2009 Mar; 12(2):246-52. PubMed ID: 19333870 [TBL] [Abstract][Full Text] [Related]
18. Induction of the ABC-transporters Mdr1/P-gp (Abcb1), mrpl (Abcc1), and bcrp (Abcg2) during establishment of multidrug resistance following exposure to mitoxantrone. Nieth C; Lage H J Chemother; 2005 Apr; 17(2):215-23. PubMed ID: 15920909 [TBL] [Abstract][Full Text] [Related]
19. Fatty acid receptor GPR120 promotes breast cancer chemoresistance by upregulating ABC transporters expression and fatty acid synthesis. Wang X; He S; Gu Y; Wang Q; Chu X; Jin M; Xu L; Wu Q; Zhou Q; Wang B; Zhang Y; Wang H; Zheng L EBioMedicine; 2019 Feb; 40():251-262. PubMed ID: 30738829 [TBL] [Abstract][Full Text] [Related]
20. Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer. Kovalev AA; Tsvetaeva DA; Grudinskaja TV Exp Oncol; 2013 Dec; 35(4):287-90. PubMed ID: 24382439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]